Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Morningstar

What Were the 3 Best-Performing Dividend Stocks in 2024?

Morningstar research shows that these high-yielding dividend stocks were winners last year. Can they keep up the outperformance in 2025?

Barchart

What to do with your 401(k) when you retire

For many employees, what to do with a 401(k) plan at retirement has been a foregone conclusion: Roll it over

The Independent UK

Cathie Wood sells $17 million of tumbling tech stock

The Nasdaq Composite has gained 34.1% in the past 12 months, while Ark Innovation ETF returned 19.1%.

The Street

From analysis to the latest developments in health,
read the most diverse news in one place.

Apple's new chief financial officer will use the same 'CFO playbook' say top analysts—and that's good news for investors

Kevan Parekh, who first joined the company in 2013, begins his tenure as finance chief.

Fortune

Tencent loses billions in market value after the U.S. alleges the video game giant has links to China’s military

The Department of Defense accused Tencent and EV battery giant CATL of having ties to China’s military. Tencent calls the decision “clearly a mistake.”

Fortune

The Pros and Cons of Investing in Private Debt

What to know about investing in private debt, including how it works and where to invest.

Kiplinger

Cathie Wood buys $10 million of beaten-down tech stock

The Nasdaq Composite gained 32% in the past year, while the ARK Innovation ETF returned just 12.6%.

The Street

Read news from The Economist, FT, and more,
with one subscription

Tarsus Pharmaceutical - Eye Care Therapeutics

Summary Tarsus Pharmaceuticals (TARS) has shown strong technical indicators, including a 48.35% gain since the Trend Seeker buy signal on 9/4 and 173.43% gain in the last year. The company focuses on novel eye care therapeutics, with its lead product XDEMVY targeting blepharitis caused by Demodex mites and other promising...

Barchart

3 must-knows about employee stock options

If stock options are part of your compensation package, it’s worth your while to get familiar with how they work generally, as well as how your company handles stock options specifically

The Independent UK

Chevron Stock Looks Cheap, Especially if it Hikes the Dividend

Chevron may raise its dividend based on its strong free cash flow. CVX looks undervalued now, trading at lows. If Chevron raises the dividend by 6.75%, the forward yield is now very high at 4.85%.

Barchart

Should you worry about overfunding your 529 plan?

529 college savings plans are powerful tools to help pay for the mounting costs of an education

The Independent UK

Four Lessons for a Happy, Successful and Wealthy Retirement

Christine Benz, Morningstar director of personal finance and retirement planning, explains the key lessons from her book on retiring successfully.

Kiplinger

Maximize Tax Savings With Strategic Tax-Loss Selling

Learn how tax-loss selling can optimize your portfolio for growth and tax efficiency. Explore Morningstar's personal finance section for more insights.

Top News

How you could benefit from tax-loss selling this year

The U.S. market gained more than 25% for the year to date through mid-December 2024

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Cathie Wood sells $70 million of surging tech stock

The Nasdaq Composite is up 32.3% this year, while the ARK Innovation ETF has returned 20.2%.

The Street

Cathie Wood buys $30 million of under-the-radar AI stock

The Nasdaq Composite is up 33.5% this year, while the ARK Innovation ETF has returned 18.03%.

The Street

Cathie Wood sells $7 million of surging stock

The Nasdaq Composite is up 33.5% this year, while the Ark Innovation ETF has returned 18.03%.

The Independent UK

How to bridge a retirement shortfall

If you want to get yourself thoroughly depressed, spend a little time looking at statistics about Americans’ retirement preparedness

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Cathie Wood sells $5 million of surging tech stock

The Nasdaq Composite is up 32.3% this year, while the ARK Innovation ETF has returned 20.1%.

The Street

Cathie Wood buys $22.1 million of battered tech stock

The Nasdaq Composite is up 29.3% this year, while the ARK Innovation ETF has returned 13.56%.

Barchart

Planet Labs - Views From Space

Summary Planet Labs PL has shown a 90.76% gain since the Trend Seeker buy signal on 10/29, driven by strong technical indicators and consistent price appreciation. The company provides high cadence geospatial data through satellite constellations, serving various sectors including agriculture, energy, finance, and government. Barchart's technical indicators show 100%...

The Independent UK

The Psychology of retirement income: A guide to saving and spending

How to manage retirement spending woes

Barchart

1 ETF to Build a Wide Moat for Your Portfolio

The VanEck Vectors Morningstar Wide Moat ETF (MOAT) stands out as a strategic investment option, focusing on companies with sustainable competitive advantages and strong economic moats, making it a compelling choice for building a resilient portfolio.

The Independent UK

Tackling estate planning in 7 basic steps

Estate planning is one of those tasks that makes almost any other job look appealing, no matter how lowly

The Street

Cathie Wood buys $38 million of surging tech stock

The Nasdaq Composite is up 24.4% this year, while the ARK Innovation ETF has returned just 2.83%.

1 2 3 4 5

People

Stephen "Sarge" Guilfoyle

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.